These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21707551)

  • 21. Determinants of disability and quality of life in mild to moderate Parkinson disease.
    Muslimovic D; Post B; Speelman JD; Schmand B; de Haan RJ;
    Neurology; 2008 Jun; 70(23):2241-7. PubMed ID: 18519873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive deterioration rates in patients with Parkinson's disease from northeastern China.
    Luo XG; Feng Y; Liu R; Yu HM; Wang L; Wu Z; Ren Y; He ZY
    Dement Geriatr Cogn Disord; 2010; 30(1):64-70. PubMed ID: 20689285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia.
    Vendette M; Gagnon JF; Décary A; Massicotte-Marquez J; Postuma RB; Doyon J; Panisset M; Montplaisir J
    Neurology; 2007 Nov; 69(19):1843-9. PubMed ID: 17984452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cognition deterioration in Parkinson's disease: associated risk factors].
    Errea JM; Ara JR
    Rev Neurol; 1999 Mar 1-15; 28(5):439-43. PubMed ID: 10229953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Odor identification deficits identify Parkinson's disease patients with poor cognitive performance.
    Damholdt MF; Borghammer P; Larsen L; Ostergaard K
    Mov Disord; 2011 Sep; 26(11):2045-50. PubMed ID: 21638326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class Analysis.
    Brennan L; Devlin KM; Xie SX; Mechanic-Hamilton D; Tran B; Hurtig HH; Chen-Plotkin A; Chahine LM; Morley JF; Duda JE; Roalf DR; Dahodwala N; Rick J; Trojanowski JQ; Moberg PJ; Weintraub D
    J Parkinsons Dis; 2017; 7(2):385-395. PubMed ID: 28387684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of executive function impairment in Parkinson's disease patients without dementia.
    McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
    J Int Neuropsychol Soc; 2010 Mar; 16(2):268-77. PubMed ID: 20003582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subtypes of Parkinson's disease defined by intellectual impairment.
    Mortimer JA; Jun SP; Kuskowski MA; Webster DD
    J Neural Transm Suppl; 1987; 24():101-4. PubMed ID: 3479520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A brief neuropsychological protocol for assessing patients with Parkinson's disease.
    Ong JC; Seel RT; Carne WF; Brown R; Pegg PO; Jehle PJ
    NeuroRehabilitation; 2005; 20(3):191-203. PubMed ID: 16340100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early neuropsychological detection and the characteristics of Parkinson's disease associated with mild dementia.
    Song IU; Kim JS; Jeong DS; Song HJ; Lee KS
    Parkinsonism Relat Disord; 2008 Nov; 14(7):558-62. PubMed ID: 18328767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Side of onset does not influence cognition in newly diagnosed untreated Parkinson's disease patients.
    Erro R; Santangelo G; Picillo M; Vitale C; Amboni M; Longo K; Giordano F; Moccia M; Barone P; Pellecchia MT
    Parkinsonism Relat Disord; 2013 Feb; 19(2):256-9. PubMed ID: 23178144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease.
    Llebaria G; Pagonabarraga J; Martínez-Corral M; García-Sánchez C; Pascual-Sedano B; Gironell A; Kulisevsky J
    Mov Disord; 2010 Dec; 25(16):2785-91. PubMed ID: 20960483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apathy may herald cognitive decline and dementia in Parkinson's disease.
    Dujardin K; Sockeel P; Delliaux M; Destée A; Defebvre L
    Mov Disord; 2009 Dec; 24(16):2391-7. PubMed ID: 19908317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction.
    Saka E; Elibol B
    Parkinsonism Relat Disord; 2009 Nov; 15(9):688-91. PubMed ID: 19446489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Side of onset of motor symptoms influences cognition in Parkinson's disease.
    Tomer R; Levin BE; Weiner WJ
    Ann Neurol; 1993 Oct; 34(4):579-84. PubMed ID: 8215246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brief cognitive assessment in the early stages of Parkinson disease.
    Bugalho P; Vale J
    Cogn Behav Neurol; 2011 Dec; 24(4):169-73. PubMed ID: 22045168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.
    Janvin CC; Larsen JP; Aarsland D; Hugdahl K
    Mov Disord; 2006 Sep; 21(9):1343-9. PubMed ID: 16721732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and patterns of cognitive impairment in sporadic ALS.
    Ringholz GM; Appel SH; Bradshaw M; Cooke NA; Mosnik DM; Schulz PE
    Neurology; 2005 Aug; 65(4):586-90. PubMed ID: 16116120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.